Applied nutritional investigationEffect of magnesium supplementation on depression status in depressed patients with magnesium deficiency: A randomized, double-blind, placebo-controlled trial
Introduction
Magnesium is the second intracellular cation and the fourth major element in the body [1]. Given the complex function that this element plays in our body, it is considered an important element for human health [2]. This element is an important coenzyme for many enzymes involved in the transfer of phosphate and energy metabolism. Additionally, magnesium has major roles in stabilizing genes, DNA replication, synthesis of protein and nucleic acids, and metabolism of macronutrients [3].
Furthermore, by regulating and transferring some ions, including potassium and calcium, through pumps and channels, magnesium also is effective in neuro-transmission [4]. Accordingly, it is involved in the pathophysiology of some neurologic diseases including migraine, Alzheimer's and Parkinson's diseases, and attention-deficit/hyperactivity disorder [2], [5]. In recent years, the role of this element in the incidence of depression, due to its effect on N-methyl-d-aspartate's (NMDA) nonselective ionotropic channels in the brain, has gained a great deal of attention [6]. These glutamate-dependent channels have important roles in neurotransmission and neuronal plasticity. Thus magnesium is involved in learning, memory, and mood of individuals [7]. NMDA channels are excited by glutamate neurotransmitter and cause entrance of sodium and calcium into the cell. Once sodium is introduced and the intracellular space is depolarized, entrance of calcium is accelerated. Calcium, then, by exciting enzymatic paths including kinase protein and synthesis of nitric oxide, plays an important role in the pathophysiology of depression [8], [9]. However, magnesium is the natural antagonist of calcium [10], whereby inhibiting NMDA ionotropic channels, it prevents entrance of calcium into the cell, thereby inhibiting the activation of its subsequent enzymatic cascade [9], [11], [12].
In many studies, the level of dietary magnesium in relation to depression has been investigated. Although the obtained results are controversial, in the majority of studies a significant relationship has been observed between deficiency of the consumed magnesium and incidence of depression [13], [14], [15]. The result of a 20-y follow-up study showed that magnesium intake may have an effect on the risk for developing depression [16].
A deficiency in dietary magnesium can be accounted for by various factors such as the soil of agricultural lands and new agricultural techniques including genetic manipulation [17], [18]. Another factor is the water being consumed. According to a study, given the amounts of minerals, drinking water can provide 8% of daily magnesium required by individuals [19]. Additionally, an unhealthy diet that contains a high consumption of processed foods and refined grains can result in hypomagnesemia in long term [2]. Therefore, although major sources of magnesium, including dark green leafy vegetables, grains, and nuts are available [20], hypomagnesemia is still seen in many metabolic diseases [21]. Among depressed people, incidence of hypomagnesemia has been estimated to be as high as 13.7% [22]. This figure is almost three times the value of nondepressed individuals (4.6%) [23].
Although the conventional treatment of depression is administration of antidepressants including selective serotonin reuptake inhibitors, monoamine oxidase inhibitors, and tricyclic antidepressants [24], not completing the treatment due to complications caused by these medications, such as headache and nausea, vomiting, restlessness, and drowsiness [25] as well as relapse of the depression or manic periods in about 60% of individuals, highlights the necessity of researching and investigating complementary treatments [26]. Furthermore, studying the effect of food supplements and nutrients such as magnesium on this disease can play an important role in the prevention and treatment of this problem.
The question is to what extent the condition of patients suffering from depression as well as a lack of magnesium can be improved in terms of depression mitigation by resolving the deficiency of magnesium. Accordingly, this research was designed and conducted with the aim of examining the effect of magnesium supplementation on the status of depression in those suffering from magnesium deficiency.
Section snippets
Type of study and participants
This was a randomized, double-blind, placebo-controlled trial with 60 individuals suffering from depression and magnesium deficiency. They were selected from patients referred to Khatam-ol-Anbiya Clinic in Yazd under the supervision of a psychiatrist and through using the Beck Depression Inventory-II questionnaire. This study was designed in two phases; initially, the status of magnesium in depressed patients was investigated. Those results were published previously [22]. In the second phase,
Results
Of 650 possible participants, 60 met the inclusion criteria and were randomly assigned to one of two groups (MG or PG). They were followed for 8 wk. At the end of the study, seven participants were excluded due to nonattendance, pregnancy, immigration, or complications caused by consumption of the tablets. Eventually, information from 26 patients in the MG and 27 in the PG was analyzed (Fig. 1). Tablet count showed a compliance of >87% in both groups.
The age mean of the MG and PG were
Conclusion
This study indicated that daily consumption of 500 mg magnesium oxide tablet for ≥8 wk by individuals with depression and hypomagnesemia results in improvement in both the depression and the status of magnesium in their bodies. Therefore, when evaluating patients with depression, evaluation of the serum magnesium status and resolving this deficiency, if present, contribute to better treatment outcomes and thus are recommended.
Acknowledgments
The authors acknowledge Shahid Sadoughi University of Medical Sciences for its continued attention and financial support of this research. They also acknowledge the officials and employees of Khatam-ol-Anbiya Clinic, the central laboratory of Shahid Sadoughi University of Medical Sciences in Yazd, and all the participants whose cooperation facilitated completion of this study.
References (37)
Regulation of magnesium homeostasis and transport in mammalian cells
Arch Biochem Biophys
(2007)N-methyl-D-aspartate (NMDA) and the regulation of mitogen-activated protein kinase (MAPK) signaling pathways: a revolving neurochemical axis for therapeutic intervention?
Prog Neurobiol
(2005)- et al.
Metabotropic glutamate receptor 5 upregulates surface NMDA receptor expression in striatal neurons via CaMKII
Brain Res
(2015) - et al.
Magnesium: nature's physiologic calcium blocker
Am Heart J
(1984) - et al.
Rapid recovery from major depression using magnesium treatment
Med Hypotheses
(2006) - et al.
Magnesium for treatment-resistant depression: a review and hypothesis
Med Hypotheses
(2010) - et al.
Magnesium intake is not related to depression risk in Spanish university graduates
J Nutr
(2012) - et al.
Dietary magnesium intake and the incidence of depression: a 20-year follow-up study
J Affect Disord
(2016) Magnesium in disease prevention and overall health
Adv Nutr
(2013)- et al.
Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: a retrospective US claims study
Clin Ther
(2012)
Electroconvulsive therapy (ECT) increases serum brain derived neurotrophic factor (BDNF) in drug resistant depressed patients
Eur Neuropsychopharmacol
Magnesium and the athlete
Curr Sports Med Rep
Magnesium in prevention and therapy
Nutrients
Biochemistry of magnesium
J Elementol
Magnesium in man: implications for health and disease
Physiol Rev
NMDA receptor subunit diversity: Impact on receptor properties, synaptic plasticity and disease
Nat Rev Neurosci
Changes in brain protein expression are linked to magnesium restriction-induced depression-like behavior
Amino Acids
Magnesium intake and depression in adults
J Am Board Fam Med
Cited by (52)
The brain-gut-microbiota interplay in depression: A key to design innovative therapeutic approaches
2023, Pharmacological ResearchProtective role of antioxidant supplementation for depression and anxiety: A meta-analysis of randomized clinical trials
2023, Journal of Affective DisordersThe relationship between nutrition and depression in the life process: A mini-review
2023, Experimental GerontologyCitation Excerpt :As a result of a seven-year study, it was found that dietary magnesium intake and the risk of depression were inversely related in women, but not in men (Sun et al., 2019). In a study conducted with 60 depressed people with hypomagnesemia, it was found that there was a significant improvement in serum magnesium levels and depression status in the intervention group given 500 mg magnesium oxide for 8 weeks (Rajizadeh et al., 2017). In another study, it was reported that there is a relationship between serum magnesium levels and depression and that magnesium supplementation can improve depressive symptoms in individuals with low serum magnesium levels (Tarleton et al., 2019).
Nutraceuticals for prevention and management of anxiety
2023, Nutraceutical Fruits and Foods for Neurodegenerative DisordersReview on correlations between depression and nutritional status of elderly patients
2022, Herbal Medicines: A Boon for Healthy Human Life
This work funded by Shahid Sadoughi University of Medical Sciences, Yazd, Iran. The authors have no conflicts of interest to declare.